Changing the Paradigm of Merkel Cell Carcinoma in Australia

“Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine tumor of the skin with an estimated disease-associated mortality of 15–33%. Australia has a higher incidence of MCC compared to the rest of the world, thought to be due to a higher ultraviolet index.” 

In this article published recently in the Asia Pacific Journal of Clinical Oncology, leading Australian experts present the latest in treatments and diagnosis of this often aggressive neuroendocrine skin cancer. 

Well done to all involved including authors David L. Kok, Annie Wang, Wen Xu, Margaret S. T. Chua, Alexander Guminski, Michael Veness, Julie Howle, Richard Tothill, Ganessan Kichendasse, Michael Poulsen, Shahneen Sandhu, Gerald Fogarty – Peter MacCallum 

To read more click below

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

Related Posts

Changes at NECA HQ

It has been a busy month here at NECA HQ as we sadly said goodbye to two of our staff members Megan Mitchell and Deanne